5:19 PM
May 31, 2013
 |  BC Extra  |  Top Story

Epizyme soars in trading debut

Epizyme Inc. (NASDAQ:EPZM) jumped $7.99 (53%) to $22.99 on Friday in its first day of trading after the cancer company raised $77.1 million in an IPO on Thursday....

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >